[1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT, Barker FG. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation // Neurosurgery, 2009; 64:56 – 60]Search in Google Scholar
[2. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas // Neurology, 2000; 54:71 – 76]Search in Google Scholar
[3. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma // Neurosurgery, 2005; 57:1088 – 1095]Search in Google Scholar
[4. Cole CD, Couldwell WT. Surgical and radiation treatment of skull base meningiomas // US Neurology, 2008;4:75 – 78]Search in Google Scholar
[5. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J. WHO grade II and III meningiomas: a study of prognostic factors // J Neurooncol, 2009; 95:367 – 375]Search in Google Scholar
[6. Evans DG. Neurofibromatosis type 2: genetic and clinical features // Ear Nose Throat J, 1999;78:97 – 100]Search in Google Scholar
[7. Louis, DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO classification of tumours of the central nervous system, 4th ed. Lyon: IARC Press; 2007.]Search in Google Scholar
[8. Mocker K, Holland H, Ahnert P, Schober R, Bauer M, Kirsten H, Koschny R, Meixensberger J, Krupp W. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics // Pathol Res Pract, 2011; 207:67 – 72]Search in Google Scholar
[9. Violaris K, Katsarides V, Sakellariou P. The recurrence rate in meningiomas: analysis of tumor location, histological grading, and extent of resection // Open Journal of Modern Neurosurgery, 2012; 2:6 – 10]Search in Google Scholar